Home / Top-News Abfall / Waste Kreislaufwirtschaft / Recycling Management Energie / Energy Märkte / Markets Unternehmen / Companies Forschung / Research Politik / Policy Recht / Law
Archiv
Zurück Impressum
 

London - Frost & Sullivan has conferred two prestigious awards on Veolia Water Solutions & Technologies (VWS). The Frost & Sullivan European Pharmaceutical Water & Wastewater Treatment Business Development Strategy Leadership Award, lauds VWS for its successful strategies that have enabled it to consolidate its position as one of the leading process water and wastewater solution providers for the pharmaceutical industry in Europe.

Veolia Water Solutions & Technologies logo
Veolia Water Solutions & Technologies
"The success of VWS in the highly process critical pharmaceutical industry is attributed to its well structured business strategies that centre on customised advanced treatment technologies and comprehensive, fully integrated treatment and service solutions," notes Frost & Sullivan Research Analyst Karthikeyan Ravikumar. "Superior product quality, coupled with effective after sales services, has resulted in high levels of customer satisfaction."

Since 2005, VWS has also been successful in offering turnkey solutions on a global basis to the pharmaceutical industry. High quality standard equipment offerings include ORION™, QUATTRO™, TRITON and POLARIS for producing Purified Water and Water for Injection. The company also offers two unique after sales services - AQUATREND™ and AQUAMOVE™.

The company has successfully shifted from a market segment-based approach (which involved the division of the water industry into three segments: municipal, industrial water and industrial wastewater treatment) to one focused on water and wastewater treatment technologies. Another initiative undertaken has been the development of centres of excellence, especially among subsidiaries. This enterprise has already materialised with dedicated Centres of Excellence for key industrial sectors such as food and beverage and pharmaceuticals. Currently, VWS is the only company in the market with a team - The Veolia Pharmaceutical Competence Centre - dedicated to the pharmaceutical industry. Lately, the company has adopted a more discerning approach to treatment technologies. It is currently equipped with a strong portfolio of thermal desalination solutions.

"This complements the Reverse Osmosis membrane capabilities built up within VWS&T, resulting in aggressive growth in the desalination plant market in the Middle East," statesFrost & Sullivan Research Analyst Fredrick Harry Royan. "This was recently highlighted when the company secured the contract of building one of the worlds largest thermal desalination plant with a capacity of 800,000 m3/day for the Jubail Industrial City in Saudi Arabia."

In the last few years, the company has adopted an aggressive growth strategy based on major acquisitions. The defining factor of the acquisition strategy has been a focus on sustainability, which is reflected in the technologies and solutions acquired in the last few years.

Veolia Water Solutions & Technologies (VWS), subsidiary of Veolia Water, is a leading design & build company and a specialized provider of technological solutions in water treatment. With over 8,900 employees in 57 countries, Veolia Water Solutions & Technologies recorded revenue of €2.5 billion Euros in 2008.

Veolia Water, the water division of Veolia Environnement, is the world leader in water and wastewater services, says Frost & Sullivan. Specialized in outsourcing services for municipal authorities, as well as industrial and service companies, Veolia Water serves 139 million people worldwide. With 93,400 employees, its 2008 revenues amounted to €12.6 billion.

Quelle: Frost & Sullivan

Ähnliche Artikel:

Artikel vom: 11.09.2009 08:31
Zurück   
© MSV Mediaservice & Verlag GmbH, Bergstr. 16, D-82239 Biburg
Sekundär-Rohstoffe